Author

Cristina Camps-Fajol

Observed name: Camps-Fajol, Cristina

Institutions: Universitat Autònoma de Barcelona, Instituto de Salud Carlos III, Centre for Biomedical Network Research on Rare Diseases, Institut de Recerca Sant Pau

Observed institutions: Universitat Autònoma de Barcelona, Instituto de Salud Carlos III, Hospital de Sant Pau, Centre for Biomedical Network Research on Rare Diseases, Institute for Bioengineering of Catalonia, Institut de Recerca Sant Pau

OpenAlex ID: A5087786682

Targeting protein-protein interactions in drug discovery: Modulators approved or in clinical trials for cancer treatment

2024 · Cristina Camps-Fajol, Debora Cavero, et al. · Pharmacological Research · 33

CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer Survival

2022 · Jordi Minguillón, María José Ramírez, et al. · Cancers · 6

High content drug screening for Fanconi anemia therapeutics

2020 · Helena Montanuy, Cristina Camps-Fajol, et al. · Orphanet Journal of Rare Diseases · 4

Synthetic lethality in cancer: mechanisms, therapeutic exploitation and clinical translation

2026 · Cristina Camps-Fajol, Jordi Minguillón, et al. · Signal Transduction and Targeted Therapy

Works count: 8

Citation count: 43

H-index: 3

I10-index: 1